Skip to main content

Bright outlook: Sun Pharma to Cipla, drug firms set for Q3 health boost

Analysts expect earnings growth to be in the range of 30-40 per cent for drug firms owing to both domestic recovery as well as strong export opportunities

from Today's Paper https://ift.tt/2XuGIak

Comments

Popular posts from this blog